Ascendis Pharma A/S / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €3.07B +20.9% €1.36B +30.6% 44.3% +0.033 pp N/A N/A
    (estimated) €2.54B +40.7% €1.04B +54.6% 41.1% +0.037 pp N/A N/A
    (estimated) €1.81B +41.5% €674.42M +168.0% 37.4% +0.18 pp €739.19M +56.6% 40.9% +0.039 pp
    (estimated) €1.28B +81.9% €251.69M -271.3% 19.7% +0.41 pp €472.00M +254.9% 37.0% +0.18 pp
    (estimated) €701.13M +92.8% -€146.93M -61.1% -21.0% +0.83 pp €133.00M -143.6% 19.0% +1.0 pp
    €363.64M +36.3% -€378.08M -21.5% -104.0% +0.77 pp -€304.77M -34.4% -83.8% +0.91 pp
    €266.72M +421.2% -€481.45M -17.4% -180.5% +9.6 pp -€464.92M -3.4% -174.3% +7.7 pp
    €51.17M +557.9% -€583.19M +52.0% -1,139.6% +38 pp -€481.21M +22.3% -940.3% +41 pp
    €7.78M +11.9% -€383.58M -8.4% -4,931.6% +11 pp -€393.42M +57.4% -5,058.0% -15 pp
    €6.95M -48.0% -€418.96M +92.2% -6,025.5% -44 pp -€250.00M +46.4% -3,595.5% -23 pp
    €13.38M +26.4% -€218.02M +67.6% -1,630.0% -4.0 pp -€170.78M +25.4% -1,276.8% +0.099 pp
    €10.58M +591.6% -€130.10M +5.0% -1,229.5% +69 pp -€136.15M +44.6% -1,286.8% +49 pp
    €1.53M -66.8% -€123.90M +80.9% -8,097.8% -66 pp -€94.16M +58.2% -6,154.1% -49 pp
    €4.61M -43.3% -€68.51M +108.1% -1,487.3% -11 pp -€59.51M +40.3% -1,291.9% -7.7 pp
    €8.12M -41.9% -€32.92M +240.9% -405.5% -3.4 pp -€42.43M +135.7% -522.6% -3.9 pp
    €13.98M -31.5% -€9.66M -336.8% -69.1% -0.89 pp -€18.00M -339.8% -128.7% -1.7 pp
    €20.41M +31.0% €4.08M +226.3% 20.0% +0.12 pp €7.51M -2,178.9% 36.8% +0.39 pp
    €15.58M €1.25M 8.0% -€361.00K -2.3%

    Notifications